Switch to:

Onconova Therapeutics Inc (ONTX) Ownership Data

Short Interest History (%)

This is the historical short interest of Onconova Therapeutics Inc, as measured by the Short Percentage Of Float.

Date Short Interest
July 15, 20151.89
June 30, 20151.94
June 15, 20151.98
May 29, 20152.08
May 15, 20152.13
April 30, 20152.26
April 15, 20152.51
March 31, 20152.36
March 13, 20151.69
February 27, 20151.73
February 13, 20153.1
January 30, 20153.13
January 15, 20153.26
December 31, 20144.49
December 15, 20146.31
November 28, 20146.17
November 14, 20146.77
October 31, 20146.9
October 15, 20147.3
September 30, 20147.45
September 15, 20147.38
August 29, 20147.62
August 15, 20148.67
July 31, 20149.84
July 15, 201411.19
June 30, 201414.6
June 13, 201414.73
May 30, 201414.64
May 15, 201415.22
April 30, 201417.51
April 15, 201415.99
March 31, 201413.43
March 14, 201410.73
February 28, 201410.07
February 14, 201413.76
January 31, 201413.03
January 15, 201412.25
December 31, 201311.93
December 13, 201311.83
November 29, 201310.16
November 15, 20137.87
October 31, 20136.2
October 15, 20134.72
September 30, 20134.22
September 13, 20132.93
August 30, 20132.2
August 15, 20131.41
July 31, 20130.89

Institutional Ownership History (%)

This the Institutional Ownership History of Onconova Therapeutics IncPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
June 30, 201529
March 31, 20155
December 31, 20148
September 30, 20149
June 30, 201410
March 31, 201426
December 31, 201316
September 30, 201318

Insider ownership (%)

This is the historical insider ownership of Onconova Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
April 30, 20158
March 31, 20158
February 28, 20158
January 31, 20158
December 31, 20148
November 30, 20148
October 31, 20148
September 30, 20148
August 31, 20148
July 31, 20148
June 30, 20148
May 31, 20148

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. E. Premkumar Reddy, PhDDirector1,337,8386.17%2014-05-02
Dr. Ramesh Kumar, PhDPresident and CEO276,5001.27%2013-02-07
Dr. Viren MehtaDirector126,9140.58%2013-07-30
Ajay BansalN/A43,8460.2%2013-07-30
Michael B. HoffmanDirector, 10% Owner18,754less than 0.1%2014-07-07
Henry S. Bienen,PhDDirector14,935less than 0.1%2013-11-15
Mr. James AltlandN/A10,000less than 0.1%2013-07-30
Dr. Thomas Mckearn, PhDPresident, R&D3,333less than 0.1%2013-07-30
Mr. Mark GuerinN/A600less than 0.1%2014-05-09

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Baxalta Inc2,603,2952015-05-0611.99N/A6,040
Baxter International Inc2,603,2952015-05-0611.99N/A6,040
Vanguard Group, Inc.   Premium Plus290,7302015-03-311.34N/A701
Weiss Multi-Strategy Advisers Llc   Premium Plus240,8722015-03-311.110.03581
Vanguard Total Stock Mkt Idx191,2992015-06-300.88N/A453
Citigroup Inc   Premium Plus135,0862015-03-310.62N/A326
Renaissance Technologies Corp Premium109,3472015-03-310.50N/A264
Alyeska Investment Group, L.P.   Premium Plus91,7522015-03-310.42N/A221
Vanguard Extended Market Index Fund89,5982015-06-300.41N/A212
Royal Bank Of Canada   Premium Plus49,6622015-03-310.23N/A120

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK